Abstract-Catechol-O-methyltransferase (COMT) metabolizes 2-hydroxyestradiol into 2-methoxyestradiol (2-ME);
C atechol-O-methyltransferase (COMT) is an enzyme known to inactivate catecholamines, such as dopamine, adrenaline, and noradrenaline. However, any compounds with a catechol structure are candidate substrates of COMT. Estradiol is metabolized to 2-hydroxyestradiol (2-OHE2) by cytochrome P450. The 2-OHE2, one of the catechol estrogens, is converted to 2-methoxyestradiol (2-ME) by COMT. The maternal circulatory 2-ME levels increases toward the end of pregnancy; however, the plasma levels of 2-ME and placental COMT activity are significantly lower in women with severe preeclampsia. [1] [2] [3] [4] Functional Val158Met COMT polymorphism has shown to be associated with preeclampsia. [5] [6] [7] [8] [9] In a large Norwegian cohort (HUNT2), a low-COMT activity haplotype was associated with recurrent preeclampsia. 10 Indeed, we have shown that COMT-deficient pregnant mice exhibited preeclampsia-like phenotypes because of 2-ME defects. 3 Not only the women's diseases but also COMT deficiency has been shown to associate with hypertension in men, 6, 11 acute coronary heart disease in men, 12 and metabolic diseases. 7, 13 Therefore, to understand the mechanisms of vascular insult associated with COMT deficiency is important for human health.
The renin-angiotensin system plays an important role in maintaining circulatory homeostasis, including gestational periods. Gant et al 14 published a seminal report about the role of the renin-angiotensin system in the pathogenesis of hypertension during pregnancy. They analyzed the angiotensin II (Ang II) doses required to elicit a pressor response of 20 mm Hg in diastolic pressure. Compared with nonpregnant women, normal pregnant women required a high dose of Ang II throughout the gestation periods. The mean required doses of Ang II for a pressor response in women who developed preeclampsia progressively declined compared with those in normotensive pregnant women, suggesting that women who developed preeclampsia have an enhanced pressor response against Ang II. In addition, women with preeclampsia had lower plasma levels of both renin activity and Ang II than normotensive pregnant women. 14 These findings indicate that hypertension in preeclampsia is associated with hypersensitivity of the pressor response against Ang II.
From the rationale of COMT deficiency in hypertensive disorder and the mechanisms of hypertension in preeclampsia, we got the hypothesis that COMT deficiency is broadly relevant for the vascular insult in human disease via hypersensitivity of pressor response against Ang II.
Methods Summary
Eight-week-old male C57BL/6 mice were subjected to COMT inhibitor Ro41-0960 (COMTi: 25 mg/kg per day IP administration) or olive oil (control) for 4 weeks, with or without low-dose Ang II infusion (ANGII: 70 ng/kg per minute continuous subcutaneous infusion) for the last 3 weeks. The Ang II-infused mice were treated with 2-ME (10 ng/d IP), 2-OHE2 (10 ng/d IP), or vehicle for the last week. We performed similar experiments using the in vivo administration of small interfering RNA (siRNA; siCOMT: 20 nmol/wk IP) of COMT instead of COMTi. To obtain the plasma of pregnant mice, 6-week-old female C57BL/6 mice were mated with male C57BL/6 mice. Beginning at day 10 of the pregnancy, the mice were injected with Ro41-0960 (25 mg/kg per day) with or without 2-ME (10 ng/d) or placebo subcutaneously. For noninvasive monitoring of blood pressure (BP), mice were trained for at least 5 days before measurement of BP. Urinary albumin and creatinine measurements were performed as described previously. Plasma Ang II and catecholamines, soluble fms-related tyrosine kinase-1 (sFlt-1), and placental growth factor-2 (PlGF-2) concentrations were measured with an ELISA system. Western blot analysis for COMT, angiotensin II type 1 receptor (AT1R), and reverse transcription polymerase chain reaction for human AT1R were performed with standard methods. Electron microscopic analysis was performed in Hanaichi Ultrastructure Research Institute (Tokyo, Japan). Peroxisome proliferator-activated receptor (PPAR) luciferase activity was evaluated using the DualLuciferase Reporter Assay System (Promega). In vitro and ex vivo experiments were performed with human aortic smooth muscle cells (AoSMCs; LONZA) or human embryonic kidney 293-T cells (HEK293Ts) overexpressing hemagglutinin-tagged mouse AT1a receptor or transfected with pcDNA (kindly gifted by Junji Ishida and Akiyoshi Fukamizu, University of Tsukuba, Japan).
Results

COMT Deficiency in Mice Exhibited Hypersensitivity to Ang II
To evaluate the role of COMT deficiency in the sensitivity to Ang II, we tested the effect of COMT deficiency in mice on systolic blood pressure (SBP) and albuminuria with low-dose ANGII ( Figure 1A) . Compared with the control group, neither the ANGII group nor the COMTi group displayed an alteration in SBP. In contrast, the SBP in the COMTi+ANGII group was significantly increased compared with the SBP in either the ANGII or COMTi group. The SBP in COMTi+ANGII was significantly decreased by the treatment with 2-ME but not by the treatment with 2-OHE2 ( Figure 1A ). The albuminuria in COMTi+ANGII was significantly increased compared with the albuminuria in both ANGII and COMTi. The 2-ME significantly reduced the levels of albuminuria in COMTi+ANGII ( Figure 1B) . A, The experimental protocol of the study is presented. Blood pressure measurements in oil (n=10), oil+Ang II infusion (ANGII; n=10), COMT inhibitor (COMTi; n=10), COMTi+ANGII (n=10), COMTi+ANGII+2-methoxyestradiol (2-ME; n=10), and COMTi+ANGII+2-hydroxyestradiol (2-OHE2; n=10) groups. Mean systolic blood pressure (SBP) at days 21 and 28 was compared across all groups. B, Urinary albumin/creatinine ratio (μg/ mg) for oil (n=5), oil+ANGII (n=6), COMTi (n=5), COMTi+ANGII (n=7), and COMTi+ANGII+2-ME (n=5) groups. C, Electron microscopy was performed for oil, oil+ANGII, COMTi, COMTi+ANGII, and COMTi+ANGII+2-ME groups. Electron micrographs of glomeruli show glomerular endotheliosis, including glomerular endothelial swelling and occlusion of the capillary lumen, as indicated by the white dotted lines. Scale bar, 1 μm. Data are expressed as the mean±SEM, P values analyzed by 1-way ANOVA with Tukey test; *P<0.05, **P<0.01.
Ultrastructure analysis revealed that COMTi+ANGII displayed glomerular endotheliosis characterized by glomerular endothelial swelling and occlusion of the lumen capillary. The 2-ME ameliorated the glomerular endothelial morphology ( Figure 1C) .
In normal male C57BL/6 mice, membrane-bound and soluble COMT proteins were highly expressed in the liver compared with their levels in the kidney, heart, and aorta ( Figure S1A in the online-only Data Supplement). In the liver, siRNA-mediated gene silencing affected membranebound COMT levels. In the kidney, the expression levels of membrane-bound and soluble COMT proteins were unaltered ( Figure S1B ). The SBP in the siCOMT+ANGII group was significantly increased compared with the SBP in both scramble (SCR) siRNA+ANGII and siCOMT groups. The SBP in the siCOMT+ANGII group was significantly decreased when the mice were treated with 2-ME ( Figure 2A ). The albuminuria in mice treated with COMT siRNA exhibited similar trends; the magnitude of differences between the groups was less than that observed with COMTi administration ( Figure 2B ).
No Association of Plasma sFlt-1, PlGF, or sFlt-1/ PlGF Levels in COMT Deficiency-Associated Hypertension Induced by Ang II sFlt-1, which is a soluble form of the vascular endothelial growth factor receptor, acts as an antagonist of vascular endothelial growth factor and PlGF. In this regard, an excess level of plasma sFlt-1 is hypothesized to contribute to the pathomechanism of hypertension in preeclampsia. 15 However, in the COMT-deficient mice treated with low-dose Ang II, the mouse plasma sFlt-1 and PlGF-2 were not correlated with their hypertension (Figure 3A and 3B; Figure S1C and S1D). In our experiment, neither sFlt-1, PlGF-2, nor the sFlt-1/PlGF-2 ratio could explain the hypertension in COMT deficiency.
Plasma Catecholamine Levels Were Not Altered in COMT-Deficient Mice
COMT is an enzyme that degrades and inactivates catecholamines. COMT deficiency might be assumed to increase the levels of catecholamines. However, COMT deficiency did not significantly influence adrenaline and noradrenaline levels in plasma as reported elsewhere 16 ( Figure 3C ).
COMT Deficiency Was Associated With the Induction of AT1R Levels
Women with preeclampsia displayed lower plasma Ang II levels when compared with normotensive pregnant women.
14 Similarly, the plasma Ang II levels in both COMTi and siCOMT were significantly decreased compared with those of each control group ( Figure 4A ). Both COMTi and siCOMT displayed normal BP, suggesting that Ang II levels of COMTdeficient mice seemed to be suppressed for the homeostasis to maintain BP at normal levels. In preeclampsia, the vascular AT1R expression was induced to a greater extent than in normal pregnancy. 17 To evaluate mechanisms for Ang II hypersensitivity, we examined whether AT1R expression in the aorta was induced in COMT deficiency. Several AT1R antibodies are available commercially but have been reported (Ang II) hypersensitivity. A, The experimental protocol of the study is presented. Blood pressure measurements in scramble (SCR) siRNA (n=10), SCRsiRNA+angiotensin II infusion (ANGII; n=10), siCOMT (n=10), siCOMT+ANGII (n=11), and siCOMT+ANGII+2-methoxyestradiol (2-ME; n=11) groups. Mean systolic blood pressure (SBP) at days 21 and 28 was compared across all groups. B, Urinary albumin/creatinine ratio (μg/mg) for SCRsiRNA (n=5), SCRsiRNA+ANGII (n=5), siCOMT (n=5), siCOMT+ANGII (n=6), and siCOMT+ANGII+2-ME (n=5) groups. Data are expressed as the mean±SEM, P values analyzed by 1-way ANOVA with Tukey test; *P<0.05, **P<0.01.
to display nonspecific binding in mouse tissues. 18 To test the specificity of the antibody used in our experiments, we first performed Western blot analysis in AoSMCs transfected with AGTR1 siRNA, and HEK293Ts overexpressing hemagglutinin-tagged mouse AT1a receptor.
19 AT1R belongs to the family of G-protein-coupled receptors that are known typical 7 transmembrane domain receptors, and encodes 359 amino acids. 20 The predicted molecular size of human and rodents AT1R form, which represent the nonglycosylated AT1R, is ≈41 kDa, whereas the glycosylated AT1R has a molecular mass of ≈65 to 150 kDa. 18, 20 By Western blot analysis, the antibody we used could detect ≈41-kDa bands in scramble Figure 4 . Catechol-O-methyltransferase (COMT)-deficient mice exhibit the elevated levels of angiotensin II type 1 receptor (AT1R) protein expression in aorta. A, ELISA of plasma angiotensin II from oil (n=4) and COMT inhibitor (COMTi; n=4), scramble (SCR) siRNA (n=4), and siCOMT (n=4). B, The panel shows a densitometric analysis of mouse aorta AT1R protein expression normalized to GAPDH (n=3) in oil, oil+ANGII, COMTi, COMTi+ANGII, and COMTi+ANGII+2-ME groups. GAPDH levels are shown as a loading control. C, The panel shows a densitometric analysis of mouse aorta AT1R protein expression normalized to GAPDH (n=3) in SCRsiRNA, SCRsiRNA+ANGII, siCOMT, siCOMT+ANGII, and siCOMT+ANGII+2-ME groups. Data are expressed as the mean±SEM, P values analyzed by 1-way ANOVA with Tukey test; *P<0.05, **P<0.01. 2-ME indicates 2-methoxyestradiol; and siRNA, small interfering RNA. Plasma soluble fms-related tyrosine kinase-1 (sFlt-1) levels and sFlt-1/placental growth factor-2 (PlGF-2) ratio, catecholamine levels are unlikely associated with the hypertension in catechol-O-methyltransferase (COMT)-deficient mice. A and B, ELISA was performed for sFlt-1 and PlGF-2 on plasma from mice in oil (n=5), oil+angiotensin II infusion (ANGII; n=5), COMT inhibitor (COMTi; n=5), COMTi+ANGII (n=5), and COMTi+ANGII+2-methoxyestradiol (2-ME; n=5) groups (A) and from mice in scramble (SCR) siRNA (n=5), SCRsiRNA+ANGII (n=5), siCOMT (n=5), siCOMT+ANGII (n=5), and siCOMT+ANGII+2-ME (n=5) groups (B). C, ELISA of plasma adrenaline and noradrenaline from oil (n=5), oil+ANGII (n=5), COMTi (n=5), COMTi+ANGII (n=5), and COMTi+ANGII+2-ME (n=5) groups. Data are expressed as the mean±SEM, P values analyzed by 1-way ANOVA with Tukey test; *P<0.05, **P<0.01; n.s. indicates nonsignificance; and siRNA, small interfering RNA.
siRNA-transfected AoSMCs; the bands were suppressed in the AoSMCs transfected with AGTR1 siRNA ( Figure S2A ). Furthermore, in HEK293Ts overexpressing hemagglutinintagged mouse AT1aR, the antibody detected higher levels of 41-kDa bands when compared with HEK293Ts transfected with pcDNA3. Antihemagglutinin antibody could detect the same band size ( Figure S2B ). These data demonstrated that the antibody we used exhibited highly specific to both human AT1R and mouse AT1aR.
In both COMTi and COMTi+ANGII groups, AT1R protein levels in the aorta were increased compared with those in control and ANGII groups; 2-ME suppressed aortic AT1R expression in COMTi+ANGII ( Figure 4B ; Figure S3A ). In both the siCOMT and siCOMT+ANGII groups, AT1R protein levels in the aorta were significantly increased compared with those in the SCRsiRNA and SCRsiRNA+ANGII groups; 2-ME suppressed aortic AT1R expression in siCOMT+ANGII ( Figure 4C ; Figure S3B ). These results suggested that mice with COMT deficiency exhibited Ang II hypersensitivity via the induction of AT1R expression in vessels; 2-ME suppressed such COMT deficiency-associated AT1R expression.
2-ME Suppressed AT1R Levels in Cultured Human Smooth Muscle Cells
Ang II increases vasoconstriction via AT1R activation in vascular smooth muscle cells. 21, 22 In AoSMCs, compared with the control, Ang II significantly induced both AT1R protein and mRNA levels; 2-ME suppressed this induction of AT1R expression (Figure 5A and 5B; Figure S3C ). COMTi significantly induced AT1R mRNA and protein levels in AoSMCs; 2-ME, but not 2-OHE2, significantly suppressed this increase in AT1R mRNA and protein levels ( Figure 5C ; Figure S3D ).
2-ME Suppressed AT1R Levels in a PPARγ-Dependent Manner
2-ME has structural similarity with PPAR ligands, 23 such as pioglitazone and rosiglitazone. The 2-ME has been shown to activate PPARγ in vascular smooth muscle cells. 23, 24 In addition, a PPARγ activator was shown to suppress AT1R expression in vascular smooth muscle cells. 25, 26 In AoSMCs, 2-ME (100 and 500 nmol/L) increased PPARγ activities to levels similar to those induced by the PPARγ agonist pioglitazone (30 μmol/L; Figure 6A ). In AoSMCs, both 2-ME and pioglitazone suppressed both mRNA and protein levels of AT1R. The PPARγ antagonist GW9662 diminished the effects of 2-ME and pioglitazone on AT1R levels ( Figure 6B ; Figure  S3E ). These results suggested that 2-ME suppressed AT1R expression in a PPARγ-dependent manner.
Plasma From COMT-Deficient Male or Pregnant Mice Exhibited Less PPARγ Transcriptional Activity
PPARγ transcriptional activity was nearly doubled in cells treated with serum from normal pregnant women when compared with those from nonpregnant women; the serum from severe preeclamptic women exhibited reduced levels of PPARγ transcriptional activity compared with the serum from normal pregnant women. 27, 28 In addition, dominant negative mutations in human PPARγ were associated with the onset of preeclampsia. 29 We found that reduced PPARγ transcriptional activity and increased AT1R protein levels in AoSMCs were induced by plasma from COMTi-treated male mice; these protein levels were diminished in plasma from male mice treated with COMTi plus 2-ME associated with the restoration of PPARγ transcriptional activity ( Figure 6C ; Figure S3F ). COMTi-treated pregnant mice, the mice exhibited preeclampsia phenotype, 3 exhibited low PPARγ transcriptional activity in plasma. Such low PPARγ transcriptional activity was associated with increased AT1R levels; 2-ME restored these levels ( Figure 6D ; Figure S3G ).
Discussion
COMT deficiency led to the hypersensitivity to Ang II with increased AT1R expression; 2-ME suppressed AT1R expression in a PPARγ-dependent manner. Previously, we showed that COMT-deficient pregnant mice displayed a preeclampsialike phenotype because of the absence of 2-ME. 3 However, the pathomechanisms of pregnancy-induced hypertension in pregnant COMT-deficient mice remained unclear. In this study, we found that COMT deficiency was indeed associated with hypersensitivity of the pressure response against Ang II. Jennings et al 30 reported that cytochrome P450 1B1, which convert estradiol into 2-OHE2, protected higher dose (700 ng/kg per minute) of Ang II-induced hypertension by 2-MEinhibiting oxidative stress and the activity of these signaling molecules. Also, we confirmed that 2-ME ameliorated lowdose (70 ng/kg per minute) Ang II-induced hypertension in COMT deficiency. Here, we found that COMT deficiency and the resultant lack of 2-ME lead to the induction of AT1R levels in vitro and in vivo. Furthermore, we found that 2-ME exhibited PPARγ agonistic activity and that such PPARγ transcriptional activity of 2-ME was important for the suppression of AT1R levels in both in vitro and ex vivo plasma experiments. The 2-ME has shown to be elevated toward the end of pregnancy. 2, 3 These data clearly demonstrate the fundamental role of 2-ME in the homeostasis of BP through the regulation of sensitivity against Ang II.
In normal pregnancy, plasma renin activity and Ang II levels are higher; however, the vascular responsiveness to Ang II seems to be reduced. In contrast, preeclamptic women exhibited lower levels of plasma renin activity and Ang II levels despite a lower plasma volume. 31, 32 Approximately 40 years ago, Gant et al 14 established a logical explanation for the hypertension mechanism of preeclampsia as hypersensitivity against Ang II. AbdAlla et al 33 found that AT1R-bradykinin B2 receptor heterodimers were increased in platelets and omental vessels from preeclamptic women, resulting in Ang II hypersensitivity. In addition, platelet Ang II binding sites were increased in women with preeclampsia. 34 Wallukat et al 35 described the presence of agonistic autoantibodies for AT1R in preeclampsia, and such agonistic autoantibodies for AT1R may facilitate hypersensitivity against Ang II. 36 These reports indicate that the pathogenic mechanisms of hypertension in preeclampsia might be related to elevated AT1R levels that induce hypersensitivity to Ang II.
When injected into pregnant mice, affinity-purified agonistic autoantibodies for AT1R from preeclamptic women lead to hypertension, proteinuria, glomerular endotheliosis, and elevated sFlt-1 levels. 37 Whereas, nonpregnant mice injected with agonistic autoantibodies for AT1R induced hypertension without proteinuria and glomerular endotheliosis, elevated sFlt-1 levels. In our study, however, the COMTi+ANGII group displayed glomerular endotheliosis without sFlt-1 induction; 2-ME ameliorated the glomerular endothelial morphology. The 2-ME has been shown to inhibit hypoxia-inducible factor-1α (HIF-1α), the molecule induced by Ang II. 3, 23, 38 Pregnant mice overexpressing HIF-1α had hypertension and proteinuria with glomerular endotheliosis. 39 Silencing of HIF-1α gene significantly improved the glomerular sclerotic damages (as indicated by glomerular mesangial expansion with hypercellularity, capillary collapse, and fibrous deposition in glomeruli) induced by ANGII (200 ng/kg per minute) in Sprague-Dawley rats. 38 It is possible that albuminuria and glomerular endotheliosis are mediated by increased HIF-1α levels. Therefore, we assume that both absence of 2-ME and infusion of low-dose Ang II, not by each of them alone, may lead to the accumulation of HIF-1α resulting in glomerular injury.
Both 2-OHE2 and 2-ME have little affinity for estrogen receptors and inhibit the growth of vascular smooth muscle cells 40, 41 , cardiac fibroblasts, 42 and renal mesangial cells. 43, 44 COMT deficiency eliminates many of the vasoprotective effects of estradiol and 2-OHE2. 40 These antigrowth effects via estrogen receptor-independent mechanisms are mediated through 2-ME. The 2-ME protects cardiovascular and renal system and reduces mortality in severe disease models. 45 Furthermore, COMT is efficient with regard to converting 2-OHE2 to 2-ME 46 and rapidly methylate 2-OHE2 in heart and kidneys. 47 These reports suggest that COMT-mediated conversion of 2-OHE2 to 2-ME plays vital protective role in cardiovascular and renal system.
Our study has several limitations. First, we used indirect methods for measuring BP in mice because (1) we repeated measurements of SBP in large numbers of conscious mice during studies of long duration, 48 and (2) pulse-based tailcuff measurements have been proven accurate by comparison to simultaneous telemetry measurements. 49, 50 Second, blood was collected into heparin-coated tube without inhibitors as reported elsewhere (such as, protease inhibitor and renin inhibitor, angiotensin-converting inhibitor). 51, 52 The measurement of plasma Ang II levels was not planned at the beginning of our experiments. Nussberger et al 53 reported that blood samples were collected in the presence of inhibitor solution for prevention of generation and degradation of Ang II. Therefore, it is possible that the Ang II levels in our study may under-or overestimate true values. Both COMT-deficient mice (inhibitor or siRNA) displayed suppressed levels of Ang II when compared with each control mice. Even though such technical limitations, the levels of Ang II in our experiments could be relevant to demonstrate the Ang II hypersensitivity in COMT deficiency. Next, we could not measure the plasma 2-ME concentration by ELISA using a commercially available system in this study. The 2-ME is present at ≈3 ng/mL (≈10 nmol/L) in the blood stream of normal pregnant women during the third trimester by high-performance liquid chromatography with mass spectrometry/mass spectrometry detection. 3 In previous study, we measured the plasma levels of 2-ME in pregnant mice, the condition associated with high 2-ME levels, and found that COMT knockout pregnant mice displayed depleted levels of 2-ME 3 ; however, even in the pregnant mice, the levels of 2-ME were low, and we did not observe any statistical significant difference between the groups, probably because of low estrogen levels in mice when compared with pregnant women. [54] [55] [56] [57] Despite these limitations, we successfully demonstrated that PPARγ transcriptional activities were upregulated by 2-ME in vitro and ex vivo. These data strongly suggest that 2-ME plays a vital role in BP regulation via the suppression of AT1R 58, 59 through PPARγ transcriptional activation. In addition, we used male C57BL/6 wild-type mice for our study. Primary purpose of our study was to investigate whether COMT deficiency could induce vascular injury in the presence of low Ang II levels; we considered analyzing female mice for our study because most strong evidence between COMT deficiency and hypertensive disorder was indeed preeclampsia. However, female mice have a short estrous cycle (≈4-5 days), which significantly alters estrogen and 2-ME levels. 60, 61 Despite these limitations, we successfully demonstrated that COMT-deficient pregnant female mice, as a model of preeclampsia, 3 exhibited the suppression of PPARγ transcriptional activity in plasma. This PPARγ suppression in COMT-deficient pregnant female mice was restored by 2-ME. Thus, COMT/2-ME deficiency is relevant in both male and female mice.
Perspectives
This study showed that COMT deficiency leads to Ang II hypersensitivity with increased vascular AT1R expression; 2-ME suppresses AT1R expression via PPARγ activation. In both men and women, low-COMT activity polymorphisms and haplotypes are associated with hypertension, 6 cardiovascular disease, 12 metabolic disease, 7, 13 and recurrent preeclampsia. 10 Preeclamptic women display a significant depletion of plasma 2-ME levels [1] [2] [3] and have a well-established association with the incident of hypertension and CVD in later life. The 2-ME is nonfeminizing because of a low affinity for estrogen receptors. Therefore, these data could provide the mechanistic rationale for the 2-ME replacement therapy to combat COMT deficiency-associated hypertensive disorders irrespective of age or sex.
